Listed pan-European healthcare and medical laboratory services provider Medicover saw its share price dip slightly, by 1.5%, as third quarter results were announced, despite a 16% jump in revenues and a 20% increase in EBITDA. India was announced as a key target for expansion, while Eastern European operations saw particularly strong growth.